X icon button to close sales banner

Save 25% on Clue Plus

Use code: HELLO25 at checkout

Subscribe now
Reading time: 2 min

Research partner profile: Dr. Alexandra Alvergne at Oxford

  • Share this article on Twitter
  • Share this article on Facebook
  • Share this article with WhatsApp

Name: Dr. Alexandra Alvergne[2]

Location: University of Oxford, United Kingdom

Profession: Associate Professor in Biocultural Anthropology

Degree: PhD in Human Evolutionary Biology and Ecology

About: Dr. Alexandra Alvergne is on a mission to help people better understand their bodies.

Alex wants to shift from a general medicalization of female health to a more holistic, ecological and evolutionary perspective. So what exactly does that mean? Currently, the medical and health industries are treating symptoms rather than considering the root of various medical conditions and problems.

Dr. Alvergne wants to take a broader look at treatment, and thinks we need to shift from a rigid "normal" vs. "pathological" perspective to a fluid ecological approach that takes into consideration diversity and change.

An ecological perspective on care and prevention would look at social, cultural, economic, political, nutritional, (epi)genetic and microbial factors. It would also avoid looking at female health through a lens that only focuses on reproductive function.

Goal: Dr. Alvergne wants to see what we can learn by researching the natural evolution and variation in menstrual cycles. Every person and cycle is different, and we can learn a lot from variation rather than automatically prescribing a pill or a fix.

She would also like to help people discover they have a sexually transmitted infection sooner, so they can get treatment as soon as possible.

How: Dr. Alvergne thinks that academia and research can move faster by partnering with businesses and focusing on user-led research.

Although Alex would like to move away from a medicalization of female health, she acknowledges that we need pharmaceutical companies. It's easy to point fingers at big pharma because in reality, they have strong economic interests. However, if they don't make money, they won't survive. Simple as that. The question is how we can direct pharmaceutical companies in a more inclusive and open direction that covers aspects of diversity. Alex thinks they could benefit from building links with nonprofits and taking a deeper look into medical anthropology.

Current research: Human ecology and fertility, contraception adoption & discontinuation, vaccination decision making

Past research: Hormonal birth control and mate choice, contraceptive uptake

Connect with Dr. Alvergne and get updates on her research. Follow her on Twitter.[3]

an illustration of the Clue flower
an illustration of the Clue flower

Live in sync with your cycle and download the Clue app today.

Was this article helpful?

You might also like to read

Menstrual Cycle

Cycle tracking puts you in charge

Clue’s Chief Medical Officer, Lynae Brayboy, shares six ways tracking with Clue can really help you–and others.

Popular Articles

an illustration of the Clue flower
an illustration of the Clue flower

Live in sync with your cycle and download the Clue app today.